Are we only a step away to use it as a treatment in every hospital?
Mice treated with the combination of canabidiol (CBD) and chemotherapy against pancreas cancer have survived three times longer than the ones treated only with cemotherapy, according to a new study. It shows the possibility of using CBD in human treatments, too.
CBD is a non-psycho-active chemical compound of cannabis, that doesn’t cause daze. It is proven for long time to reduce the side effects of cemotherapy: nausea and vomiting.
The latest results justify the competence of tests done on people based on previous animal experiments, that discover the possible anti-cancerous effects of the chemical.
„Using cannabidiol (CBD) is already authorized in the clinics of UK. It means we can start testing on human clinical examinations.” – said Marco Falasca leading researcher on London Queen Mary University.
In opposite to the UK, where experiments on people cured with CBD against cancer can go on faster, similar intentions in the USA where CBD produced from cannabis is still considered illegal (first category) according to the Federal Law. However Food and Drug Administration (FDA) has approved the first medicine containing CBD for treatment of serious epilepsy, June this year.
Pancreas cancer is among the most deadly cancerous diseases worldwide considering the surviving rata. According to American Cancer Society the ratio of surviving in all phases of pancreas cancer in one year is 20 %, and the ratio of surviving in 5 years is under 7 %.
It is the 12th most frequent cancer in the developed countries.
The lifetime of sick persons with pancreas cancer has hardly changed in the last 40 years. Mostly pallative medical treatments are available – added dr. Falasca in a statement.
„Because the 5 year survival rate of pancreas cancerous patients is less then 7 %, urgently new treatments, therapic strategies are needed to discovered.”
Although this experiment has not been tested on people, the results emphesize the continous research with cannabis compounds.
As long as the legalisation movement started to gather ground, the studies about cannabis compounds have effected many promising results about the mitigation of the symptoms of migrain, recovering from strokes and reduction the gravity of epileptic attacks.
The more we know about these compounds’ potency, the more it can be seen that the block of medical researches for decades by the Federal Law has releived us from medical science’s development. Now it starts to be brought to light.